🔎 Trials Near Me

Početna › Ewingov sarkom › Ohio

Kliničke studije za Ewingov sarkom u državi Ohio

8 studija za Ewingov sarkom traži sudionike na lokacijama u državi Ohio.

Gradovi u državi Ohio

Službeni tekst studije (engleski)

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

  • Cleveland Clinic Children's, Cleveland
  • Nationwide Children's Hospital, Columbus
U tijeku regrutacijaFaza 1
Od 1 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07194044

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • Cincinnati Children's Hospital Medical Center, Cincinnati
U tijeku regrutacijaFaza 1
Od 12 do 85 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT03715933

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Cincinnati Children's Hospital Medical Center, Cincinnati
U tijeku regrutacijaFaza 1/2
12 Months – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT04851119

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

  • Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT05210374

Single Arm Romiplostim to Prevent CIT

  • Cincinnati Children's Hospital Medical Center, Cincinnati
U tijeku regrutacijaRana faza 1
Od 1 godina i više · Oba spola · Ažurirano 18. ožu 2026. · NCT07048249

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

  • The Ohio State University Wexner Medical Center, Columbus
U tijeku regrutacija
Od 13 godina i više · Oba spola · Ažurirano 6. velj 2026. · NCT06387485

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
U tijeku regrutacijaFaza 1/2
Od 2 do 30 godina · Oba spola · Ažurirano 3. velj 2026. · NCT05734066

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Nationwide Children's Hospital, Columbus
U tijeku regrutacijaFaza 2
18 Months – 40 Years · Oba spola · Ažurirano 12. kol 2025. · NCT05135975

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.